Ameritas Investment Partners’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $221K | Buy |
|
|||||
|
2025
Q1 | $190K | Hold |
|
|||||
|
2024
Q4 | $194K | Buy |
|
|||||
|
2024
Q3 | $166K | Hold |
|
|||||
|
2024
Q2 | $140K | Hold |
|
|||||
|
2024
Q1 | $121K | Hold |
|
|||||
|
2023
Q4 | $118K | Hold |
|
|||||
|
2023
Q3 | $99.2K | Buy |
|
|||||
|
2023
Q2 | $99.3K | Buy |
|
|||||
|
2023
Q1 | $89.7K | Hold |
|
|||||
|
2022
Q4 | $86.7K | Sell |
|
|||||
|
2022
Q3 | $104K | Hold |
|
|||||
|
2022
Q2 | $108K | Hold |
|
|||||
|
2022
Q1 | $137K | Hold |
|
|||||
|
2021
Q4 | $188K | Hold |
|
|||||
|
2021
Q3 | $170K | Sell |
|
|||||
|
2021
Q2 | $759K | Hold |
|
|||||
|
2021
Q1 | $882K | Buy |
|
|||||
|
2020
Q4 | $569K | Sell |
|
|||||
|
2020
Q3 | $566K | Hold |
|
|||||
|
2020
Q2 | $664K | Sell |
|
|||||
|
2020
Q1 | $446K | Sell |
|
|||||
|
2019
Q4 | $671K | Sell |
|
|||||
|
2019
Q3 | $688K | Sell |
|
|||||
|
2019
Q2 | $836K | Sell |
|
|||||
|
2019
Q1 | $971K | Sell |
|
|||||
|
2018
Q4 | $1.09M | Buy |
|
|||||
|
2018
Q3 | $479K | Hold |
|
|||||
|
2018
Q2 | $361K | Buy |
|
|||||
|
2018
Q1 | $286K | Sell |
|
|||||
|
2017
Q4 | $246K | Hold |
|
|||||
|
2017
Q3 | $231K | Hold |
|
|||||
|
2017
Q2 | $218K | Buy |
|
|||||
|
2017
Q1 | $174K | Buy |
|